Nepaze Ophthalmic Suspension is a pharmaceutical formulation containing Nepafenac at a concentration of 0.1% (w/v). This suspension is designed for topical ocular administration in patients with inflammatory conditions associated with ocular surgery, such as posterior segment and anterior chamber procedures. Nepafenac, a non-steroidal anti-inflammatory drug (NSAID), acts by inhibiting cyclooxygenase (COX-1 and COX-2), thereby reducing inflammation, pain, and the risk of post-operative complications. The use of Nepaze Ophthalmic Suspension contributes to a faster recovery and improves the overall success rate of ocular surgical interventions. However, it is essential to follow the prescribed dosage and administer the drops carefully to ensure optimal therapeutic effects and minimize potential side effects.